Implanted neurosphere-derived precursors promote recovery after neonatal excitotoxic brain injury

Luigi Titomanlio1, Myriam Bouslama, Virginia Le Verche

  • 1Inserm, U676, Hopital Robert Debré, Paris, France.

Insights

Neural stem cell therapy shows promise for treating infant brain damage from excitotoxicity, a cause of cerebral palsy. Early implantation reduced lesion size and improved memory in neonatal mice, suggesting a potential future treatment.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Neonatal Neurology

Background:

  • Excitotoxic brain damage is a primary cause of cerebral palsy in infants, leading to lifelong neurological deficits.
  • Current therapeutic options for neonatal excitotoxic brain injury are limited.
  • Neural stem cell therapy has shown potential in animal models but requires further investigation in neonates.

Purpose of the Study:

  • To evaluate the efficacy of neural stem cell therapy in a neonatal mouse model of excitotoxic brain injury.
  • To assess the survival, migration, and differentiation of implanted neurosphere-derived precursors.
  • To determine the impact of cell therapy on lesion size and behavioral outcomes in neonates.

Main Methods:

  • A neonatal mouse model of cerebral palsy was induced using ibotenate treatment on postnatal day 5.
  • Neurosphere-derived precursors or fibroblasts were implanted into injured and control brains.
  • Cell fate was tracked via immunohistochemistry; behavioral tests assessed functional recovery after early or late implantation.

Main Results:

  • Implanted neurosphere-derived precursors migrated to the lesion site, remaining undifferentiated initially and differentiating into oligodendrocytes and neurons later.
  • Despite eventual cell death, cell therapy significantly reduced lesion size and improved memory performance compared to controls.
  • Both early and late implantation showed therapeutic benefits in the neonatal mouse model.

Conclusions:

  • Cell therapy using neurosphere-derived precursors is a potential therapeutic strategy for acute excitotoxic brain injury in neonates.
  • The procedure triggered endogenous repair mechanisms, leading to reduced brain damage and improved cognitive function.
  • Further research is warranted to optimize cell therapy for clinical application in neonates.